Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aggressive Fibromatosis Therapy
Scientists at European Institute of Oncology describe research in aggressive fibromatosis therapy
May 18th, 2009
Data detailed in 'Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literature' have been presented. "Desmoid tumor, also known as aggressive fibromatosis, is a rare soft tissue tumor. For those cases localized in the anterior abdominal wall, radical resection and reconstruction with a mesh is indicated," researchers in Milan, Italy report. "Because the rarity of the disease, randomized trials are lacking, but in reported retrospective series, it is clear that although it is considered a benign lesion, local recurrence is not uncommon. We analyzed the records of 14 consecutive patients (3 men, 11 women, mean...
Source: Biotech Business Week (2009-05-18)
|
